Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Synthesis Lectures on Biomedical Engineering is Scopus-indexed (Q4, CiteScore 1.1). Published by Springer Nature.
Checked against the index lists dated .
ISSN 1930-0328Verify ISSN ↗1930-0336Verify ISSN ↗
Publisher: Springer Nature
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 270 / 325 | 17th | Q4 |
| Biomedical Engineering | 290 / 342 | 15th | Q4 |
| Bioengineering | 150 / 168 | 11th | Q4 |
| Biochemistry | 403 / 448 | 10th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present (also 2017, 2005–2015), best quartile Q4, CiteScore 1.1.
Synthesis Lectures on Biomedical Engineering is Q4 in Biotechnology (rank 270 of 325), Q4 in Biomedical Engineering (rank 290 of 342) and Q4 in Bioengineering (rank 150 of 168), by CiteScore 2025. It is ranked in 4 subject areas in all.
Synthesis Lectures on Biomedical Engineering is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.1, quartile Q4, 17th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Synthesis Lectures on Biomedical Engineering is published by Springer Nature. Its print ISSN is 1930-0328 and its online ISSN is 1930-0336.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Synthesis Lectures on Biomedical Engineering has an h-index of 20 and a 2-year mean of 0.92 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q4. On 2-year citations it ranks #229 of 309 Scopus journals in Biotechnology.
Synthesis Lectures on Biomedical Engineering published 28 papers in 2025; its busiest recent year was 2023 with 49. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.